Prostate cancer: 6. Surgical treatment of localized disease

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 10, 1998, Pages 1265-1271

  Goldenberg, S Larry ^a,b   Ramsey, Ernest W ^c   Jewett, Michael A S ^d,e,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; HUMAN; MALE; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY;

EID: 0032542019     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nam RK, Jewett MAS, Krahn MD. Prostate cancer: 2. Natural history. CAMJ 1998;159(6):685-91
2. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-8.
3. Partin AW, Kattan MW, Subong ENP, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;277:1445-51.
4. Cleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996;47:708-12.
5. Goldenberg SL, Klotz LH, Srigley J, Jewett MAS, Mador D, Fradet Y, et al. Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol 1996;156:873-7.
6. Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 1996;155:213-9.
7. Ramsey EW, Milner J, Casiro M. Quality of life (QL) following radical retropubic prostatectomy. A general population study. Can J Urol 1998;45: 497A.
8. Igel TC, Barrett DM, Segura JW, Benson RCJ, Rife CC. Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic proscatectomy. J Urol 1987;137:1189-91.
9. Leandri P, Rossignol G, Gauthier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992;147:883-7.
10. Walsh PC: Radical retropubic prostatectomy. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr, editors. Campbell's urology. Philadelphia: WB Saunders; 1992. p. 2865-86.
11. Keetch, DW, Andriole GL, Catalona WJ. Complications of radical retropubic prostatectomy. Am Urol Assoc Update Ser 1994;13:46-51.
12. Goad JR, Eastham JA, Fitzgerald KB, Kattan MW, Collini MP, Yawn DH, et al. Radical retropubic prostatectomy: limited benefit of autologous blood donation. J Urol 1995;154:2103-9.
13. Monk TG, Goodnough LT, Brikmeyer JD, Brecher ME, Catalona WJ. Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion 1995;35:559-65.
14. Litwiller SE, Djavan B, Klopukh BV, Richiev JC, Roehrborn CG. Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10 year period (1984-1994). Urology 1995;45:813-22.
15. Borland RN, Walsh PC. The management of rectal injury during radical retropubic prostatectomy. J Urol 1992;147:905-7.
16. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation and outcomes. JAMA 1993;269:2633-6.
17. Mark DH. Mortality of patients after radical prostatectomy: analysis of recent Medicare claims. J Urol 1994;152:896-8.
18. Optenberg SA, Wojcik BE, Thompson LM. Morbidity and mortality following radical prostatectomy: a national analysis of civilian health and medical program of the uniformed services beneficiaries. J Urol 1995;153:1870-2.
19. Surya BV, Provet J, Johanson KE, Brown J. Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol 1990;143:755-8.
20. Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991;145:512-5.
21. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492-7.
22. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150:905-7.
23. Geary ES, Dendinger TE, Freiha FS, Stamey TA. Nerve sparing radical prostatectomy: a different view. J Urol 1995;154:145-9.
24. Fowler JE Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The national Medicare experience: 1988-1990 (updated June 1993). Urology 1993;42:622-9.
25. Jonler M, Messing EM, Rhodes PR, Bruskewitz RC. Sequelae of radical prostatectomy. Br J Urol 1994;74:352-8.